43 results on '"Giesel, Frederik Lars"'
Search Results
2. Deescalated225Ac-PSMA-617 Versus177Lu/225Ac-PSMA-617 Cocktail Therapy: A Single-Center Retrospective Analysis of 233 Patients
3. What is important to young medical technologists for radiology when choosing a job?: Results of a survey on job attractiveness among MTR trainees.
4. Deescalated 225Ac-PSMA-617 Versus 177Lu/225Ac-PSMA-617 Cocktail Therapy: A Single-Center Retrospective Analysis of 233 Patients.
5. 225Ac-PSMA-617 for Therapy of Prostate Cancer
6. What is important to young medical technologists for radiology when choosing a job?
7. Initial clinical experience performing sialendoscopy for salivary gland protection in patients undergoing 225Ac-PSMA-617 RLT
8. Conventional Imaging, MRI and 18F-FDG PET/MRI for N and M Staging in Patients with Newly Diagnosed Breast Cancer
9. Evaluation of Astatine-211-Labeled Fibroblast Activation Protein Inhibitor (FAPI): Comparison of Different Linkers with Polyethylene Glycol and Piperazine
10. Schwierigkeiten im Patientenmanagement bei vermeintlich unauffälliger MR-Prostatografie
11. A Revised Version of the TNM Classification Leads to Optimized Predictive Performance in Patients with Adrenocortical Carcinoma
12. Positive FAPI-PET/CT in a metastatic castration-resistant prostate cancer patient with PSMA-negative/FDG-positive disease
13. Conventional Imaging, MRI and 18 F-FDG PET/MRI for N and M Staging in Patients with Newly Diagnosed Breast Cancer.
14. Schwierigkeiten im Patientenmanagement bei vermeintlich unauffälliger MR-Prostatografie.
15. Dual-Layer Spectral Detector CT in Comparison with FDG-PET/CT for the Assessment of Lymphoma Activity
16. Dual-Layer Spectral Detector CT in Comparison with FDG-PET/CT for the Assessment of Lymphoma Activity.
17. FAP-Imaging in Rare Cancer Entities - First Clinical Experience in a Broad Spectrum of Malignancies
18. Kommentar zu „177 Lu-PSMA-617 beim metastasierten, kastrationsresistenten Prostatakarzinom".
19. Positive FAPI-PET/CT in a metastatic castration-resistant prostate cancer patient with PSMA-negative/FDG-positive disease
20. MRI for identification of progression in brain tumors: from morphology to function
21. Response Prediction of 177Lu-PSMA-617 Radioligand Therapy Using Prostate-Specific Antigen, Chromogranin A, and Lactate Dehydrogenase
22. Dosimetry Estimate and Initial Clinical Experience with 90Y-PSMA-617
23. 225Ac-PSMA-617 for Therapy of Prostate Cancer.
24. Response prediction of 177Lu-PSMA-617 RLT using PSA, Chromogranin A, and LDH.
25. Initial clinical experience performing sialendoscopy for salivary gland protection in patients undergoing 225Ac-PSMA-617 RLT
26. Intraindividual Comparison of 99mTc-Methylene Diphosphonate and Prostate-Specific Membrane Antigen Ligand 99mTc-MIP-1427 in Patients with Osseous Metastasized Prostate Cancer
27. 3D-Printed masks as a new approach for immobilization in radiotherapy - a study of positioning accuracy
28. Dosimetry Estimate and Initial Clinical Experience with 90Y-PSMA-617.
29. Initial clinical experience performing sialendoscopy for salivary gland protection in patients undergoing 225Ac-PSMA-617 RLT.
30. Intraindividual Comparison of 99mTc-Methylene Diphosphonate and Prostate-Specific Membrane Antigen Ligand 99mTc-MIP-1427 in Patients with Osseous Metastasized Prostate Cancer.
31. WITHDRAWN: Stability of cerebral activation patterns in patients with first-episode schizophrenia and a healthy control group using functional MRI
32. Gadofluorine M Uptake in Stem Cells as a New Magnetic Resonance Imaging Tracking Method
33. Positron Emission Tomography Imaging of Macrophages in Cancer.
34. Efficacy of Targeted Radionuclide Therapy Using [ 131 I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant Melanoma.
35. In Vivo Biodistribution and Efficacy Evaluation of NeoB, A Radiotracer Targeted to GRPR, in Mice Bearing Gastrointestinal Stromal Tumor.
36. Kommentar zu '177Lu-PSMA-617 beim metastasierten, kastrationsresistenten Prostatakarzinom'
37. What is important to young medical technologists for radiology when choosing a job?
38. Deescalated 225 Ac-PSMA-617 Versus 177 Lu/ 225 Ac-PSMA-617 Cocktail Therapy: A Single-Center Retrospective Analysis of 233 Patients.
39. [Patient management difficulties in case of supposed negative prostate mpMRI].
40. Dual-Layer Spectral Detector CT in Comparison with FDG-PET/CT for the Assessment of Lymphoma Activity.
41. Response Prediction of 177 Lu-PSMA-617 Radioligand Therapy Using Prostate-Specific Antigen, Chromogranin A, and Lactate Dehydrogenase.
42. Dosimetry Estimate and Initial Clinical Experience with 90 Y-PSMA-617.
43. Intraindividual Comparison of 99m Tc-Methylene Diphosphonate and Prostate-Specific Membrane Antigen Ligand 99m Tc-MIP-1427 in Patients with Osseous Metastasized Prostate Cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.